CERO THERAPEUTICS HOLDINGS, INC. (CERO) AI Dilution Summary
Updated Nov 14, 2026
Estimated cash was $429,539 as of 2026-11-13. That estimate is rolled forward from $455,925 at the 2026-09-30 balance-sheet date, against estimated monthly burn of $1,011,344. Between that date and 2026-11-13 the company received $1,424,673 net in advances under its SRX Global secured note, and its most recent offering was a $150,000 note private placement closed 2026-08-11.